What is the Impact Factor of Lung Cancer: Targets and Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Lung Cancer: Targets and Therapy is 3.30, ranking in quartile Q2 of Web of Science (ESCI).

Is Lung Cancer: Targets and Therapy indexed in Web of Science or Scopus?

Yes, Lung Cancer: Targets and Therapy is indexed in Web of Science (ESCI, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.028 (Q2) and an H-index of 32.

Who publishes Lung Cancer: Targets and Therapy and what is the Article Processing Charge (APC)?

Lung Cancer: Targets and Therapy is published by Dove Medical Press. The estimated Article Processing Charge (APC) is approximately $3,370 USD, subject to institutional waivers and corresponding author affiliations.

WoS ESCI Q2Scopus Q2SCImago #4,679Hybrid

Lung Cancer: Targets and Therapy

Identifier (ISSN):1179-2728(Print)

•

Publisher:Dove Medical Press

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

3.3– 0

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Lung Cancer: Targets and Therapy

WoS Q2

Annual Impact Factor Metric

Current (2026):3.3

Scopus SJR & RankScopus Q2

1.028

#4,679

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

32 papers with at least that number of citations each

WoS: ESCIQ2

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

8articles/year

97.67% Gold OA•16.67% Original Research

Aims & Scope

Lung Cancer: Targets and Therapy (ISSN: 1179-2728) is a peer-reviewed international scholarly journal in the field of Medicine, published by Dove Medical Press in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 3.30, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 1.028 (Q2), an H-index of 32.

Topics Covered (Recognized by AI)

Medicine98.8%Biology97.5%Internal medicine96.3%Oncology92.6%Pathology92.6%Genetics89.6%Lung cancer88.3%Cancer77.3%Chemistry58.9%Surgery58.9%Biochemistry50.9%Cancer research37.4%Radiology32.5%Receptor32.5%Gene31.3%Chemotherapy30.1%Epidermal growth factor receptor24.5%Immunology21.5%Bioinformatics21.5%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

ONCOLOGY

Rank158/333

IndexESCI

JCIESCI2026

ONCOLOGY

Rank185/333

IndexESCI

Category	Index	Rank	Quartile
ONCOLOGY	JCRESCI	158/333	Q2
ONCOLOGY	JCIESCI	185/333	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.3

Articles / Year8

Total Citations1

2025

IF3.3

Articles / Year17

Total Citations25

2024

IF—

Articles / Year19

Total Citations87

2023

IF3.6

Articles / Year12

Total Citations100

2022

IF—

Articles / Year8

Total Citations97

Year	Impact Factor	Articles / Year	Total Citations
2026	3.3	8	1
2025	3.3	17	25
2024	—	19	87
2023	3.6	12	100
2022	—	8	97
2021	—	14	360
2020	—	13	168
2019	—	15	319
2018	—	14	460
2017	—	25	794
2016	—	17	555
2015	—	9	170

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,679Scopus Q2SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

1.028

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.94

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,370 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations114

3-Year Documents39

Citable Documents23

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 8 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,370 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.